. 2020 Dec; 18(1):316.
doi: 10.1186/s12957-020-02089-y.

Efficacy of chemotherapy for lymph node-positive luminal A subtype breast cancer patients: an updated meta-analysis

Yilun Li 1 Li Ma 2 
  • PMID: 33267822
  •     36 References
  •     2 citations


Objective: To assess the association between chemotherapy and prognosis of patients with breast cancer of luminal A subtype and lymph node-positive, luminal A subtype breast cancer METHODS: Articles published between January 1, 2010, and May 1, 2020, were collected from PubMed, Embase, and Web of Science databases. On the basis of a test for heterogeneity, we selected the random effects model or fixed effects model for meta-analysis. Article quality was evaluated by sensitivity analysis, and Begg's and Egger's tests were used to measure publication bias.

Results: Six eligible articles were identified. The hazard ratio of overall survival of luminal A breast cancer patients who received both chemotherapy and endocrine therapy was 1.73 (95% CI 1.23, 2.43). The hazard ratio of overall survival for lymph node-positive, luminal A breast cancer patients who received chemotherapy and endocrine therapy was 1.86 and 95% CI 1.26, 2.81. The hazard ratio of relapse-free survival to disease-free survival was 1.30 (95% CI 0.85, 1.77). Tumor size, vascular invasion, and age did not show significant correlations with breast cancer prognosis.

Conclusion: Compared with endocrine therapy alone, the addition of chemotherapy did not improve the prognosis of patients with luminal type A and lymph node positive cancer; instead, side effects of the additional chemotherapy may have negatively affected prognosis. Prospective studies are needed to determine whether the number of positive lymph nodes also correlates with efficacy of chemotherapy of luminal type A breast cancer.

Keywords: Luminal A; Lymph node-positive breast cancer; Meta-analysis; Prognosis.

The relationship of lymphatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: a systematic review and meta-analysis.
Song Zhang, Dong Zhang, +5 authors, Liguang Zou.
Oncotarget, 2016 Dec 08; 8(2). PMID: 27926511    Free PMC article.
Systematic Review.
Is adjuvant chemotherapy omissible in women with T1-2 stage, node-positive, luminal A type breast cancer?
Hee Yong Kwak, Byung Joo Chae, +5 authors, Byung Joo Song.
J Chemother, 2015 May 15; 27(5). PMID: 25974160
Differential prognostic impact of comorbidity.
William L Read, Ryan M Tierney, +4 authors, Jay F Piccirillo.
J Clin Oncol, 2004 Jul 31; 22(15). PMID: 15284260
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
A Goldhirsch, W C Wood, +4 authors, Panel members.
Ann Oncol, 2011 Jun 29; 22(8). PMID: 21709140    Free PMC article.
Highly Cited.
Effect of chemotherapy for luminal a breast cancer.
Naotaka Uchida, Takako Suda, Kiyosuke Ishiguro.
Yonago Acta Med, 2013 Sep 14; 56(2). PMID: 24031152    Free PMC article.
Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer.
Hyojin Kim, Kyung-Hun Lee, +7 authors, Han Suk Ryu.
Virchows Arch, 2015 Aug 19; 467(5). PMID: 26280894
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
William J Gradishar, Benjamin O Anderson, +32 authors, Rashmi Kumar.
J Natl Compr Canc Netw, 2020 Apr 08; 18(4). PMID: 32259783
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy.
Zeina N Al-Mahayri, George P Patrinos, Bassam R Ali.
Front Pharmacol, 2020 May 01; 11. PMID: 32351390    Free PMC article.
Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
Hideo Shigematsu, Mai Nishina, +2 authors, Shinji Ozaki.
World J Surg Oncol, 2019 Feb 25; 17(1). PMID: 30797231    Free PMC article.
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
A S Coates, E P Winer, +6 authors, Panel Members.
Ann Oncol, 2015 May 06; 26(8). PMID: 25939896    Free PMC article.
Highly Cited.
Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma.
Domagoj Kustic, Franjo Lovasic, +3 authors, Silvana Petretic-Majnaric.
Rev Med Chil, 2019 Dec 21; 147(5). PMID: 31859887
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
A Goldhirsch, E P Winer, +5 authors, Panel members.
Ann Oncol, 2013 Aug 07; 24(9). PMID: 23917950    Free PMC article.
Highly Cited.
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial.
Torsten O Nielsen, Maj-Brit Jensen, +4 authors, Bent Ejlertsen.
Clin Cancer Res, 2016 Sep 08; 23(4). PMID: 27601592
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Hyman B Muss, Donald A Berry, +7 authors, Cancer and Leukemia Group B Experience.
J Clin Oncol, 2007 Aug 21; 25(24). PMID: 17704418
Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer? A retrospective Multicenter Study.
Daniel Herr, Manfred Wischnewsky, +10 authors, Achim Wöckel.
PLoS One, 2019 Jul 10; 14(7). PMID: 31283775    Free PMC article.
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet, 2005 May 17; 365(9472). PMID: 15894097
Highly Cited.
Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype.
Mansoor Alramadhan, Jai Min Ryu, +8 authors, Jeong Eon Lee.
Breast, 2016 Oct 05; 30. PMID: 27697675
Adjuvant chemotherapy may improve survival of patients with luminal A breast cancer and positive lymph nodes.
Y Han, Q Li, +6 authors, Y Fan.
Genet Mol Res, 2015 Sep 09; 14(3). PMID: 26345787
Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal.
CA Cancer J Clin, 2019 Jan 09; 69(1). PMID: 30620402
Highly Cited.
Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women.
Glenda M Delgado-Ramos, Syed Sameer Nasir, Jiajing Wang, Lee S Schwartzberg.
Breast Cancer Res Treat, 2020 May 25; 182(2). PMID: 32447595
Positive sentinel node in luminal A-like breast cancer patients - implications for adjuvant chemotherapy?
Axel Stenmark Tullberg, Dan Lundstedt, Roger Olofsson Bagge, Per Karlsson.
Acta Oncol, 2018 Nov 09; 58(2). PMID: 30407093
Coffee consumption and risk of breast cancer: an up-to-date meta-analysis.
Xiu Juan Li, Zhao Jun Ren, +4 authors, Jian Zhong Wu.
PLoS One, 2013 Jan 12; 8(1). PMID: 23308117    Free PMC article.
The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era.
N C Verheuvel, I van den Hoven, +2 authors, R M H Roumen.
Ann Surg Oncol, 2014 Sep 11; 22(2). PMID: 25205303
Molecular classification of breast carcinomas using tissue microarrays.
Grace Callagy, Elena Cattaneo, +4 authors, Carlos Caldas.
Diagn Mol Pathol, 2003 Feb 27; 12(1). PMID: 12605033
Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer.
Chris Twelves, Maria Jove, Andrea Gombos, Ahmad Awada.
Crit Rev Oncol Hematol, 2016 Feb 10; 100. PMID: 26857987
Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer.
Sungmin Park, Se Kyung Lee, +7 authors, Seok Jin Nam.
Medicine (Baltimore), 2017 Jun 01; 96(22). PMID: 28562530    Free PMC article.
The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?
Yadong Sun, Xiaofeng Liu, +8 authors, Jiaxiang Wang.
Tumour Biol, 2016 Jan 23; 37(7). PMID: 26790445
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression Summary.
Harold J Burstein, Christina Lacchetti, Jennifer J Griggs.
J Oncol Pract, 2016 Mar 05; 12(4). PMID: 26931400
Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement.
Hideo Shigematsu, Kenichi Taguchi, Hiroko Koui, Shinji Ohno.
Ann Surg Oncol, 2014 Dec 06; 22(7). PMID: 25476029
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, +20 authors, Breast Cancer Intergroup of North America.
Lancet Oncol, 2009 Dec 17; 11(1). PMID: 20005174    Free PMC article.
Highly Cited.
Is adjuvant chemotherapy necessary for Luminal A-like breast cancer?
Halil Taskaynatan, Yuksel Kucukzeybek, +7 authors, Mustafa Oktay Tarhan.
J BUON, 2018 Oct 26; 23(4). PMID: 30358189
Omission of chemotherapy for low-grade, luminal A N1 breast cancer: Patterns of care and clinical outcomes.
Waqar Haque, Vivek Verma, +3 authors, Bin S Teh.
Breast, 2018 Jul 15; 41. PMID: 30007270
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.
Michael J Bradburn, Jonathan J Deeks, Jesse A Berlin, A Russell Localio.
Stat Med, 2006 Apr 06; 26(1). PMID: 16596572
Highly Cited.
Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN.
R F D van la Parra, P G M Peer, M F Ernst, K Bosscha.
Eur J Surg Oncol, 2011 Feb 15; 37(4). PMID: 21316185
Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman.
BMJ, 2003 Sep 06; 327(7414). PMID: 12958120    Free PMC article.
Highly Cited. Review.
False-negative frozen section of sentinel nodes in early breast cancer (cT1-2N0) patients.
Zhu-Jun Loh, Kuo-Ting Lee, +5 authors, Hui-Ping Hsu.
World J Surg Oncol, 2021 Jun 24; 19(1). PMID: 34158071    Free PMC article.
KIN17 promotes tumor metastasis by activating EMT signaling in luminal-A breast cancer.
Qiyuan Huang, Kashif Rafiq Zahid, +9 authors, Tao Zeng.
Thorac Cancer, 2021 May 20; 12(13). PMID: 34008927    Free PMC article.